Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000394

Chief Financial Officer sold 762 shares at an average $525.23 ($400,222)

  • Chief Financial Officer acquired 662 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-28 Sale : show line 1 in the form −100 $525.18 $52,518 10,755 D
2021-10-29 Exercise or conversion : show line 2 in the form +662 $125.05 $82,783 11,417 D
2021-10-29 Sale : show line 3 in the form −662 $525.23 $347,704 10,755 D
Open-market sales · 762 sh · avg $525.23 · $400,222

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-29 Exercise or conversion : show line 4 in the form Stock Options (Right to Buy) −662 56,411 D
Loading xslF345X03/edgar.xml…